David Westaway

Active 1981–2025

90
Papers
23,268
Citations
74
h-index
89
i10-index

Citations

Citations per year for David Westaway1922: 2 citations1981: 5 citations1982: 5 citations1983: 8 citations1984: 8 citations1985: 14 citations1986: 50 citations1987: 55 citations1988: 51 citations1989: 51 citations1990: 91 citations1991: 141 citations1992: 114 citations1993: 77 citations1994: 139 citations1995: 94 citations1996: 82 citations1997: 153 citations1998: 151 citations1999: 175 citations2000: 196 citations2001: 307 citations2002: 281 citations2003: 323 citations2004: 273 citations2005: 252 citations2006: 296 citations2007: 254 citations2008: 293 citations2009: 268 citations2010: 308 citations2011: 285 citations2012: 287 citations2013: 228 citations2014: 224 citations2015: 182 citations2016: 173 citations2017: 182 citations2018: 128 citations2019: 402 citations2020: 389 citations2021: 363 citations2022: 273 citations2023: 204 citations2024: 222 citations2025: 130 citations2026: 1 citations1923–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,881 citing papers, 32.1% of this breakdownUnited Kingdom: 651 citing papers, 7.3% of this breakdownGermany: 564 citing papers, 6.3% of this breakdownChina: 513 citing papers, 5.7% of this breakdownCanada: 479 citing papers, 5.3% of this breakdownJapan: 365 citing papers, 4.1% of this breakdownItaly: 358 citing papers, 4% of this breakdownFrance: 327 citing papers, 3.7% of this breakdownSwitzerland: 246 citing papers, 2.7% of this breakdownAustralia: 236 citing papers, 2.6% of this breakdownSpain: 206 citing papers, 2.3% of this breakdownIndia: 172 citing papers, 1.9% of this breakdown
0%32.1%Other 22%

Fields

  • Medicine55.1%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Neuroscience7.1%
  • Nursing2.1%
  • Immunology and Microbiology0.6%
  • Agricultural and Biological Sciences0.5%
  • Other2.3%

Topics

  • Alzheimer's disease research and treatments17.6%
  • Prion Diseases and Protein Misfolding8.5%
  • Neurological diseases and metabolism4.6%
  • Trace Elements in Health4.5%
  • Cholinesterase and Neurodegenerative Diseases4.5%
  • Computational Drug Discovery Methods3.8%
  • Other56.5%

Coauthors

All papers

Open in search
  1. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations

    Authors: , , , , , , , , , , , , , - Cell 2010 cited by 1,216

  2. Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2001 cited by 954

  3. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 707

  4. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 1997 cited by 1,267

  5. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , - Nature 2000 cited by 1,434

  6. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits

    Authors: , , , , , , , , , , , , , , , , , , , - Brain 2010 cited by 429

  7. Oleic Acid Ameliorates Amyloidosis in Cellular and Mouse Models of Alzheimer's Disease

    Authors: , , , - Brain Pathology 2010 cited by 138

  8. The cellular prion protein binds copper in vivo

    Authors: , , , , , , , , , , , , - Nature 1997 cited by 1,270

  9. Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology

    Authors: , , , , , , , , , , - Neuroscience Research 2002 cited by 155

  10. Bioenergetic Mechanisms in Astrocytes May Contribute to Amyloid Plaque Deposition and Toxicity

    Authors: , , , - Journal of Biological Chemistry 2015 cited by 89

  11. Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease

    Authors: , , , , , , , , , , , - Science Translational Medicine 2022 cited by 60

  12. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques

    Authors: , , , , , , , , , , , - Cell 1989 cited by 698

  13. A cellular gene encodes scrapie PrP 27-30 protein

    Authors: , , , , , , , , , , , - Cell 1985 cited by 1,504

  14. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication

    Authors: , , , , , , , , , , , , - Cell 1990 cited by 870

  15. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene

    Authors: , , , , , , , , - Cell 1986 cited by 832

  16. Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2006 cited by 364

  17. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.

    Authors: , , , - 2004 cited by 349

  18. TMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2006 cited by 297

  19. VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival

    Authors: , , , , , , , , - Scientific Reports 2013 cited by 130

  20. Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis

    Authors: , , , - Molecular Neurobiology 2012 cited by 117

  21. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease

    Authors: , , , - Neuroscience 2010 cited by 102

  22. RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine

    Authors: , , , , , , , , , - Current Alzheimer Research 2006 cited by 61

  23. Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons

    Authors: , , , , , , , , , - The Journal of Cell Biology 1999 cited by 312

  24. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2012 cited by 112